Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Celsion Corp. (CLSN) to Present at the ROTH Capital Partners 24th Annual Conference

Celsion is an oncology company focused on the development and commercialization of innovative cancer drugs and tumor-targeting treatments using focused heat energy in combination with its heat-activated liposomal drug technology. Celsion has established research, license, or commercialization agreements with leading institutions, including the National Institutes of Health, Duke University, University of Hong Kong, the University of Pisa, and the UCLA Department of Medicine, Kyungpook National University Hospital and the Beijing Cancer Hospital. For more information visit the company’s Web site at www.celsion.com

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com

Let us hear your thoughts below:

This year's annual ROTH Conference will take place at The Ritz Carlton located in Laguna Niguel, on March 17-12, 2013. Bringing together executives from more than 400 growth companies, the ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com.
This entry was posted in ROTH Capital Partners Conference. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *